These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27301678)

  • 1. Selective photodepletion of malignant T cells in extracorporeal photopheresis with selenorhodamine photosensitizers.
    McIver ZA; Kryman MW; Choi Y; Coe BN; Schamerhorn GA; Linder MK; Davies KS; Hill JE; Sawada GA; Grayson JM; Detty MR
    Bioorg Med Chem; 2016 Sep; 24(17):3918-3931. PubMed ID: 27301678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selenorhodamine photosensitizers for photodynamic therapy of P-glycoprotein-expressing cancer cells.
    Hill JE; Linder MK; Davies KS; Sawada GA; Morgan J; Ohulchanskyy TY; Detty MR
    J Med Chem; 2014 Oct; 57(20):8622-34. PubMed ID: 25250825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selenorhodamine photosensitizers with the Texas-red core for photodynamic therapy of cancer cells.
    Kryman MW; Davies KS; Linder MK; Ohulchanskyy TY; Detty MR
    Bioorg Med Chem; 2015 Aug; 23(15):4501-4507. PubMed ID: 26105712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended rhodamine photosensitizers for photodynamic therapy of cancer cells.
    Davies KS; Linder MK; Kryman MW; Detty MR
    Bioorg Med Chem; 2016 Sep; 24(17):3908-3917. PubMed ID: 27246858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between 8-methoxypsoralen and 5-aminolevulinic acid in killing T cells of photopheresis patients ex vivo.
    Holien T; Gederaas OA; Darvekar SR; Christensen E; Peng Q
    Lasers Surg Med; 2018 Jul; 50(5):469-475. PubMed ID: 29460964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma.
    Shiue LH; Couturier J; Lewis DE; Wei C; Ni X; Duvic M
    Photodermatol Photoimmunol Photomed; 2015 Jul; 31(4):184-94. PubMed ID: 25772268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal photochemotherapy induces bona fide immunogenic cell death.
    Tatsuno K; Yamazaki T; Hanlon D; Han P; Robinson E; Sobolev O; Yurter A; Rivera-Molina F; Arshad N; Edelson RL; Galluzzi L
    Cell Death Dis; 2019 Aug; 10(8):578. PubMed ID: 31371700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature.
    Quaglino P; Knobler R; Fierro MT; Savoia P; Marra E; Fava P; Bernengo MG
    Int J Dermatol; 2013 Nov; 52(11):1308-18. PubMed ID: 23786842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photopheresis in cutaneous T-cell lymphoma: five-year experience.
    Crovetti G; Carabelli A; Berti E; Guizzardi M; Fossati S; De Filippo C; Bertani E
    Int J Artif Organs; 2000 Jan; 23(1):55-62. PubMed ID: 12118838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal photopheresis reduces the number of mononuclear cells that produce pro-inflammatory cytokines, when tested ex-vivo.
    Bladon J; Taylor P
    J Clin Apher; 2002; 17(4):177-82. PubMed ID: 12494410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal photopheresis in cutaneous T-cell lymphoma. Inconsistent data underline the need for randomized studies.
    Russell-Jones R
    Br J Dermatol; 2000 Jan; 142(1):16-21. PubMed ID: 10651689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracorporeal photopheresis of cutaneous T-cell lymphoma is associated with reduction of peripheral CD4+ T lymphocytes.
    Zouboulis CC; Schmuth M; Doepfmer S; Dippel E; Orfanos CE
    Dermatology; 1998; 196(3):305-8. PubMed ID: 9621137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal photopheresis: what is it and when should it be used?
    Scarisbrick J
    Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ECP versus PUVA for the treatment of cutaneous T-cell lymphoma.
    Geskin L
    Skin Therapy Lett; 2007 Jun; 12(5):1-4. PubMed ID: 17609808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal photopheresis differentially regulates the expression of phosphorylated STAT-1 and STAT-5 in treated monocytes and T cells, respectively.
    Bladon J; Taylor P
    J Cutan Med Surg; 2004; 8(3):148-56. PubMed ID: 15578129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and Sézary Syndrome.
    Zic JA
    Dermatol Clin; 2015 Oct; 33(4):765-76. PubMed ID: 26433848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal photopheresis: a focus on apoptosis and cytokines.
    Bladon J; Taylor PC
    J Dermatol Sci; 2006 Aug; 43(2):85-94. PubMed ID: 16797926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of Extracorporeal Photopheresis for the Treatment of Patients With Erythrodermic (Stage T
    Peacock A; Dehle F; Mesa Zapata OA; Prince HM; Gennari F; Taylor C
    Value Health; 2022 Jun; 25(6):965-974. PubMed ID: 35667784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.
    McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ;
    Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.